Tag Archives: IVD

Biocartis launches CE-marked IVD RAS liquid biopsy tests developed under partnership with Merck KGaA, Darmstadt, Germany. The Idylla™ ctRAS liquid biopsy tests detect RAS mutations in patients with...

Read More »